Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.11 USD | +2.00% | -2.29% | +21.09% |
May. 31 | Vanda Pharmaceuticals to Commercialize Treatment of Multiple Sclerosis in the US | MT |
May. 27 | Global markets live: UBS, Tesla, Nvidia, Apple, Micron... |
Business Summary
Number of employees: 203
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapies
100.0
%
| 254 | 100.0 % | 193 | 100.0 % | -24.27% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 254 | 100.0 % | 193 | 100.0 % | -24.27% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 02-10-31 | |
Kevin Moran
DFI | Director of Finance/CFO | 40 | 12-11-30 |
Scott Howell
HRO | Human Resources Officer | - | 19-07-31 |
Kim Wijkstrom
SAM | Sales & Marketing | 58 | 19-08-20 |
Tim Williams
LAW | General Counsel | 48 | 18-08-12 |
Corporate Officer/Principal | 55 | 03-05-31 | |
Corporate Officer/Principal | 73 | 05-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Dugan
BRD | Director/Board Member | 82 | 05-11-30 |
Chief Executive Officer | 64 | 02-10-31 | |
Stephen Mitchell
BRD | Director/Board Member | 72 | 20-02-13 |
Anne Ward
BRD | Director/Board Member | 52 | 19-10-27 |
Phaedra Chrousos
BRD | Director/Board Member | 44 | 19-04-23 |
Tage Honoré
BRD | Director/Board Member | 73 | 23-03-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 58,198,273 | 56,353,833 ( 96.83 %) | 0 | 96.83 % |
Company contact information
Vanda Pharmaceuticals, Inc.
2200 Pennsylvania Avenue NW Suite 300E
20037, Washington
+202 734 3400
http://www.vandapharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.09% | 297M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- VNDA Stock
- Company Vanda Pharmaceuticals Inc.